MedTrace Logo

Influence of Additional Physician's Consultations and Short Message Service (SMS) Reminders to Patient Compliance

NCT04863274 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2912

Last updated 2021-05-05

No results posted yet for this study

Summary

A systematic collection of retrospective and prospective data based on non-interventional patient observation, aimed to assess the risks, course and outcomes of a disease or a group of diseases:

* the retrospective part: database of patients with cardiovascular risks;
* the prospective part: observation of patients in the real world medical practice.

Conditions

  • Lipid Metabolism Disorders

Interventions

DRUG

atorvastatin

Profound patients' consultations (different from standard practice) on the importance of primary prevention of cardiovascular diseases, including preventive administration of statins. Subjects in profound consultation group will receive regular reminders (2 times a month) via SMS and phone calls to check following the doctor's recommendations and remind about follow-up visit to study centre.

Sponsors & Collaborators

  • National Research Center for Preventive Medicine

    collaborator OTHER_GOV

  • The League of Clinical Research, Russia

    lead OTHER

Principal Investigators

  • Svetlana I Elkonina, MD · League of Clinical Research (LeagueCRR)

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-21
Primary Completion
2020-10-15
Completion
2020-10-15
FDA Drug
Yes

Countries

  • Russia

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04863274 on ClinicalTrials.gov